Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E31.14 EPS (ttm)1.13 Insider Own0.04% Shs Outstand6.10B Perf Week0.86%
Market Cap214.12B Forward P/E13.25 EPS next Y2.65 Insider Trans-30.91% Shs Float6.06B Perf Month-3.80%
Income6.99B PEG4.66 EPS next Q0.62 Inst Own71.90% Short Float0.79% Perf Quarter3.76%
Sales52.29B P/S4.10 EPS this Y-21.50% Inst Trans-3.06% Short Ratio2.14 Perf Half Y18.92%
Book/sh10.34 P/B3.39 EPS next Y7.55% ROA4.20% Target Price39.35 Perf Year13.13%
Cash/sh3.43 P/C10.22 EPS next 5Y6.68% ROE10.90% 52W Range27.48 - 37.08 Perf YTD11.70%
Dividend1.20 P/FCF35.40 EPS past 5Y1.60% ROI7.30% 52W High-5.37% Beta0.86
Dividend %3.42% Quick Ratio1.10 Sales past 5Y-5.60% Gross Margin77.80% 52W Low27.67% ATR0.41
Employees97900 Current Ratio1.40 Sales Q/Q-62.00% Oper. Margin17.60% RSI (14)48.51 Volatility1.11% 1.10%
OptionableYes Debt/Eq0.70 EPS Q/Q-73.00% Profit Margin13.40% Rel Volume0.76 Prev Close34.84
ShortableYes LT Debt/Eq0.49 EarningsAug 02 BMO Payout101.70% Avg Volume22.36M Price35.09
Recom2.20 SMA20-1.20% SMA50-0.73% SMA2008.71% Volume16,955,693 Change0.72%
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Apr-07-16Resumed Morgan Stanley Equal-Weight $35
Apr-07-16Resumed JP Morgan Overweight $38
Nov-25-15Upgrade Sun Trust Rbsn Humphrey Reduce → Neutral
Nov-03-15Reiterated Argus Buy $41 → $46
Oct-28-15Reiterated Deutsche Bank Buy $41 → $43
Oct-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $35 → $38
Jul-29-15Reiterated Argus Buy $39 → $41
Jun-17-15Initiated Piper Jaffray Overweight
Apr-30-15Reiterated Argus Buy $36 → $39
Apr-29-15Downgrade Citigroup Buy → Neutral
Jan-28-15Reiterated Argus Buy $35 → $36
Dec-18-14Reiterated Deutsche Bank Buy $34 → $35
Jul-02-13Downgrade Standpoint Research Hold → Sell $24
Apr-15-13Reiterated Barclays Equal Weight $25 → $32
Jan-30-13Reiterated UBS Buy $29 → $31
Jan-30-13Reiterated Argus Buy $28 → $32
Aug-23-16 04:27PM  S&P 500, Nasdaq close near records as housing data boosts stocks at MarketWatch
02:39PM  Pfizer & Medivation: A Big Win Like Gilead-Pharmasset or a Big Bust Like Bristol-Inhibitex? at Barrons.com
11:11AM  Top 6 Pharmaceutical Companies Globally at Investopedia
10:10AM  Stock Market News for August 23, 2016
10:00AM  Top 10 Shareholders of Pfizer (PFE) at Investopedia
09:38AM  Tiger Cub Lee Ainslie Warns About Valuations, Reveals Major Q2 Moves at Insider Monkey
09:30AM  Deals of the Day: Apple Gets a Gliimpse, Pfizer's Steep Price at The Wall Street Journal
09:16AM  Pfizer Expands Cancer Drug Portfolio with the Acquisition of Medivation
09:04AM  Pfizers Medivation Acquisition: What You Need to Know
09:03AM  Your first trade for Tuesday, August 23 at CNBC
08:58AM  Pfizer Has Had A Busy M&A Year...Or Has It?
08:47AM  Medivation (MDVN) Stock Downgraded After Pfizer Deal
08:41AM  3 Value Stocks Senior Citizens Could Buy Right Now at Motley Fool
07:45AM  Jacobs Awarded Design Contract for Pfizer Global Biotechnology Center in China Business Wire
07:01AM  What Pfizer Gets in Its $14 Billion Medivation Deal at Motley Fool
06:59AM  Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016 Business Wire
04:50AM  Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised)
12:23AM  PRESS DIGEST- New York Times business news - Aug 23
12:18AM  PRESS DIGEST - Wall Street Journal - Aug 23 Reuters
12:09AM  [$$] Pfizers Medivation Deal Latest in Long Line of Similar Acquisitions at The Wall Street Journal
12:09AM  [$$] Pfizer to Buy Medivation for $14 Billion at The Wall Street Journal
12:07AM  [$$] Medivation Ovation: Pfizer Pays the Price for Growth at The Wall Street Journal
Aug-22-16 11:45PM  Asian stocks in summer lull as markets await Yellen speech
11:36PM  M&A is key to Pfizer's sales growth: Strategist
11:05PM  The $150 million winner and the losers in Pfizer's $14 billion takeout of Medivation at bizjournals.com
08:56PM  [$$] Pfizer Adds Key Cancer Drug With $14 Billion Medivation Deal at The Wall Street Journal
08:04PM  PRESS DIGEST- British Business - August 23 Reuters
07:24PM  Business Highlights
07:19PM  Pfizer-Medivation cash deal is hard to justify: Analyst
07:02PM  Cramer: Forget biotech! THIS is the next red-hot takeover group at CNBC
07:01PM  Cramer: A Bunch of Semis Are Ripe for the Picking
06:54PM  Stocks Calm As Crude Plunges; Busy Day For Medical Sector
06:51PM  Pfizer Acquires Medivation
06:39PM  Pfizer boosts cancer drug roster with $14 billion Medivation deal Reuters
05:32PM  In possible $14 billion ending, Medivation goes back to early days at bizjournals.com
05:25PM  Biotech's next big deal?
05:06PM  Pfizer (PFE) Bought Medivation (MDVN), but is it a Good Deal?
05:04PM  What Happened in the Stock Market Today at Motley Fool
04:58PM  What's Driving the M&A in Health Care?
04:56PM  [$$] Marathon Oil slips on broad sector fall at Financial Times
04:31PM  Stocks End Little-Changed; Zoe's Kitchen Plunges After Hours
04:31PM  Medivation shares leap on Pfizer's $14 billion offer at CNBC
04:29PM  Pfizer-Medivation Deal Reignites Biotech Buyout Speculation
04:27PM  Pfizer's Medivation buy seen prescribing more biotech M&A Reuters
04:27PM  Pfizer-Medivation Deal Headlines Busy Merger Monday
04:13PM  Pfizer-Medivation Close to Signing $14B Acquisition Deal? (revised)
04:10PM  Here's a Reason Why Tesaro (TSRO) Stock Climbed Today
04:05PM  Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise
04:02PM  Stocks Waver as Investors Wait for Fed Clarity
04:00PM  STOCKS SEESAW: Here's what you need to know
02:57PM  After Medivation, These 6 Biotech Stocks Could Be M&A Targets Next at Barrons.com
02:47PM  Stocks Struggle for Direction as Jackson Hole Conference Looms
02:35PM  Bernie Sanders Just Called Out Pfizer and Medivation on Twitter
01:59PM  U.S. stocks pressured as mood turns cautious ahead of Yellen speech at MarketWatch
01:57PM  [$$] Pfizer swallows Medivation in effort to conquer cancer at Financial Times
01:24PM  [$$] Pfizer makes $14bn bet on cancer drugmaker Medivation at Financial Times
01:23PM  [$$] Pfizer/Medivation: combination therapy at Financial Times
01:14PM  Biotechs Rise on Bet Medivation Losers Will Look to Next Deal
01:08PM  Pfizer to buy Medivation
12:52PM  [$$] Medivation Ovation: Pfizer Pays the Price for Growth at The Wall Street Journal
12:46PM  Medivation shareholders should be thrilled about price of Pfizer deal: analysts at MarketWatch
12:36PM  Monday links: work and drudgery
12:33PM  Pfizer Claims Pharmaceutical's Latest Big Prize
12:33PM  Pfizer Claims Pharmaceutical's Latest Big Prize at Bloomberg
12:22PM  [$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions at The Wall Street Journal
12:12PM  Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back at TheStreet
12:07PM  Incyte (INCY) Stock Rises on Takeover Speculation After $14 Billion Pfizer, Medivation Deal
11:57AM  Biotech stocks rally as investors bet on the next big tie-up at CNBC
11:46AM  Pfizer spends $14B on Medivation in cancer fight
11:16AM  Medivation's Shares Soar on Confirmation of a Pfizer Buyout at Motley Fool
11:16AM  Crude Selloff, Health Care Rally Split Wall Street
10:50AM  Upstart banks just yanked another big deal away from Wall Street at CNBC
10:39AM  Understanding Medivations Premium Valuation
10:28AM  Pfizer spent $14 billion on a company with just one approved drug here's why that's a game-changer
10:26AM  More Squawk from Jim Cramer: Pfizer Buys Medivation (MDVN) for $14 Billion
10:21AM  Nasdaq Turns Up; Medivation, Syngenta, Intersil Soar On Merger News
10:20AM  Pfizer Won the Bidding War for Medivation But Is It Really a Win? at Barrons.com
10:10AM  Stock Market News for August 22, 2016
09:53AM  Pfizer Will Buy Cancer Drugmaker Medivation For $14 Billion
09:45AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Medivation, Inc. to Pfizer Inc. is Fair to Shareholders -- MDVN Accesswire
09:20AM  Deals of the Day: Pfizer Nabs Medivation, Syngenta Deal Gets U.S. Approval at The Wall Street Journal
09:20AM  Blog Coverage Pfizer Gets Negative News from UKs MHRA and Positive News from US FDA
09:16AM  Why Pfizer, Medivation, GM, and 2 Other Stocks Have Investors Talking at Insider Monkey
09:11AM  Pfizer Is Buying Medivation for $14 Billion at TheStreet
09:09AM  Pfizer boosts cancer drug pipeline with $14 bln Medivation deal
09:07AM  McDonald's, Verizon And 3 Others That May Drag Down The Dow at Forbes
08:53AM  BOUTIQUE BLOWOUT: 3 tiny firms will make a killing on a $14 billion pharma deal
08:36AM  Morning Movers: Medivation Soars as Pfizer Wins Bidding War; Valeant Jumps at Barrons.com
08:30AM  Pfizer buying biopharm firm focused on oncology for $14B at bizjournals.com
08:28AM  Sanofi says talked with Medivation, but will be "disciplined" acquirer
08:14AM  Pfizer to buy Medivation in $US14b deal AAP
08:13AM  PFIZER INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exh
07:55AM  Pfizer Pays a Big Premium for Medivation at 24/7 Wall St.
07:48AM  Early movers: MDVN, PFE, CST, ISIL, SYT, FB, VIAB, VLKAY, JPM, MAT & more at CNBC
07:38AM  Pfizer agrees to buy cancer behemoth Medivation for $14 billion at MarketWatch
07:38AM  Global stocks, oil turn lower ahead of Fed meeting
07:25AM  Pfizer Tops Sanofi in $14 Billion Medivation Deal
07:25AM  Pfizer Tops Sanofi in $14 Billion Medivation Deal at Bloomberg
07:20AM  [$$] Pfizer agrees $14bn takeover of Medivation at Financial Times
07:06AM  Five Things You Need to Know to Start Your Day
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; and collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., and Merck KGaA. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMELIO FRANK AExecutive Vice PresidentMay 26Option Exercise24.43100,0002,443,000472,994May 27 11:03 AM
DAMELIO FRANK AExecutive Vice PresidentMay 26Sale34.49100,0003,449,115372,994May 27 11:03 AM
CANGIALOSI LORETTA VSr. Vice President, ControllerMay 24Option Exercise25.8786,0002,224,820271,663May 26 10:07 AM
CANGIALOSI LORETTA VSr. Vice President, ControllerMay 24Sale33.9786,0002,921,147185,663May 26 10:07 AM
YOUNG JOHN DGroup PresidentMay 10Option Exercise25.8741,7001,078,779200,399May 11 06:04 PM
DAMELIO FRANK AExecutive Vice PresidentMay 10Option Exercise24.43192,0004,690,560564,994May 11 06:04 PM
YOUNG JOHN DGroup PresidentMay 10Sale33.5341,7001,398,277158,699May 11 06:04 PM
DAMELIO FRANK AExecutive Vice PresidentMay 10Sale33.66192,0006,462,579372,994May 11 06:04 PM
READ IAN CChairman & CEOMay 09Option Exercise25.74275,0007,078,2501,471,738May 11 06:03 PM
SUSMAN SALLYExecutive Vice PresidentMay 09Option Exercise22.2823,884532,136199,735May 11 04:35 PM
HILL CHARLES HExecutive Vice PresidentMay 09Sale33.8429,6001,001,65160,828May 11 04:35 PM
SUSMAN SALLYExecutive Vice PresidentMay 09Sale33.7167,8842,288,669131,851May 11 04:35 PM
READ IAN CChairman & CEOMay 09Sale33.80275,0009,295,0391,196,738May 11 06:03 PM
SUSMAN SALLYExecutive Vice PresidentMay 05Option Exercise22.2856,0161,248,036231,867May 06 09:51 AM
SUSMAN SALLYExecutive Vice PresidentMay 05Sale33.7156,0161,888,144175,851May 06 09:51 AM
SUSMAN SALLYExecutive Vice PresidentMay 04Option Exercise22.2820,100447,828195,951May 06 09:51 AM
SUSMAN SALLYExecutive Vice PresidentMay 04Sale33.8720,100680,762175,851May 06 09:51 AM
DAMELIO FRANK AExecutive Vice PresidentMay 03Sale33.6587,0792,930,208372,994May 05 05:27 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 24Option Exercise18.90110,9812,097,541274,756Feb 26 03:05 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 24Option Exercise18.9062,4531,180,362140,772Feb 26 03:05 PM
OLSON LAURIE JExecutive Vice PresidentFeb 24Option Exercise18.9018,984358,79889,467Feb 26 03:05 PM
READ IAN CChairman & CEOFeb 24Option Exercise18.90584,11211,039,7172,030,151Feb 26 03:05 PM
SUSMAN SALLYExecutive Vice PresidentFeb 24Option Exercise18.90110,9812,097,541263,151Feb 26 03:05 PM
YOUNG JOHN DGroup PresidentFeb 24Option Exercise18.9052,570993,573188,679Feb 26 03:05 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 24Option Exercise18.9034,171645,832210,943Feb 26 03:05 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 24Option Exercise18.90210,2803,974,292622,467Feb 26 03:05 PM
Dolsten MikaelPresident R&DFeb 24Option Exercise18.90210,2803,974,292577,902Feb 26 03:05 PM
HILL CHARLES HExecutive Vice PresidentFeb 24Option Exercise18.9078,8551,490,360149,135Feb 26 03:05 PM
JOHNSON RADY AExecutive Vice PresidentFeb 24Option Exercise18.9019,188362,65366,048Feb 26 03:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 24Option Exercise18.9034,171645,832149,482Feb 26 03:05 PM
BOURLA ALBERTGroup PresidentFeb 24Option Exercise18.9030,666579,587144,675Feb 26 03:03 PM
BOURLA ALBERTGroup PresidentDec 15Option Exercise26.2030,000786,000140,560Dec 16 06:46 PM
YOUNG JOHN DGroup PresidentDec 14Option Exercise26.2031,500825,300163,999Dec 16 06:55 PM
PFIZER INC10% OwnerOct 06Buy7.00714,2854,999,9952,253,509Oct 07 05:42 PM